Cold Spring Harbor Laboratory  
Contact Us | Faculty & Staff Directory

Media Contact

Public Affairs


Leemor Joshua-Tor
Professor & HHMI Investigator

Ph.D., The Weizmann Institute of Science, 1991
Areas of Research:
Structural biology; nucleic acid regulation; RNAi; molecular recognition; X-ray crystallography

View Faculty Page


Follow us on

  facebook-icon twitter-icon instagram-icon3 youtube-icon wordpress-icon2
  rss-icon email-icon linkedin-icon flipboard icon

In a role reversal, RNAs proofread themselves

Molecular photographs of an enzyme bound to RNA reveal a new, inherent quality control mechanism

Cold Spring Harbor, NY – Building a protein is a lot like a game of telephone: information is passed along from one messenger to another, creating the potential for errors every step of the way. There are separate, specialized enzymatic machines that proofread at each step, ensuring that the instructions encoded in our DNA are faithfully translated into proteins. Scientists at Cold Spring Harbor Laboratory (CSHL) have uncovered a new quality control mechanism along this path, but in a remarkable role reversal, the proofreading isn’t done by an enzyme. Instead, one of the messengers itself has a built-in mechanism to prevent errors along the way.

joshuator-1292015A molecular photograph of the CCA-adding enzyme in complex with an RNA reveals a remarkable, new proofreading mechanism. In general, enzymatic machines are responsible for weeding out and correcting errors. But a team of CSHL and MIT scientists has found that the CCA-adding enzyme (shown here in blue, green, and purple) doesn’t edit at all. Instead, the RNA (in orange) has a built-in mechanism that allows it to proofread itself.
The building blocks for proteins are carried by molecules known as transfer RNAs (tRNAs). tRNAs work with other cellular machinery to ensure that the building blocks – amino acids – are arranged in the proper order. But before a building block can be loaded onto a tRNA molecule, a three-part chemical sequence that scientists call “CCA” must be added to the tRNA. The letters are added by an appropriately named machine, the CCA-adding enzyme, and they mark the tRNA as a fully functional molecule.

If a tRNA is mutated, the CCA-adding enzyme duplicates its message. The letters now read “CCACCA,” signaling that the tRNA is flawed. The cell rapidly degrades the aberrant tRNA, preventing the flawed message from propagating.

But how does the CCA-adding enzyme distinguish between normal and mutant tRNAs?

CSHL Professor and Howard Hughes Medical Institute Investigator Leemor Joshua-Tor led a team of researchers to investigate how the CCA-adding enzyme makes this distinction. “We used X-ray crystallography – a type of molecular photography – to observe the enzyme at work, and we were surprised to find that the enzyme doesn’t discriminate at all,” explains Joshua-Tor. “In fact, it is the RNA that is responsible for proofreading itself.”

The team used two tRNA-like molecules, called noncoding RNAs, to study the error-correcting mechanism. In previous work, Jeremy Wilusz, PhD, a former CSHL Watson School of Biological Sciences graduate student and an author on this current publication, found a noncoding RNA that is modified with a single CCA group, making it both stable and abundant. Another RNA used in the current study is normally present at negligible levels in cells, and Wilusz and CSHL Professor David Spector found that it is modified with a CCACCA sequence and is rapidly degraded. The difference between the two noncoding RNAs is a simple mutation, and the question the team addressed is how the presence of the mutation affects the addition of “CCA” sequences. 

joshuator-1292015bThe CCA-adding enzyme acts as a molecular vise (blue, green, purple structure), modifying RNAs with a CCA sequence using a screw-like motion. After the full sequence has been added, a normal RNA cannot turn further and pops out of the enzyme (labeled 2a). But mutations can render the RNA more flexible allowing it to refold on the enzyme (labeled 2b). It is only after a second round of CCA addition that the mutant RNA is released from the enzyme. The CCACCA sequence targets the RNA for immediate degradation in the cell. In work published online today in Cell, the team describes a series of molecular photographs of the CCA-adding enzyme bound to the noncoding RNAs. “The CCA-adding enzyme uses a screw-like motion to add each letter of the CCA group to the end of the RNA,” says Claus Kuhn, PhD, lead author on the paper. “Under normal circumstances, after the addition of the final letter A, the enzyme tries to ‘turn’ the molecule again, but can’t.” That increased pressure forces the RNA to pop out of its union with the enzyme – with only a single CCA group attached.

But when an RNA is mutated, the researchers found, the structure becomes more flexible. After a single CCA addition, the mutation allows the RNA to buckle under increased pressure. “That bulge allows the enzyme to add an additional round of “CCA” letters, and only then does the RNA pop out,” says Joshua-Tor.

This is a very unique proofreading mechanism, according to Joshua-Tor. “For the enzyme, there is no difference between the two RNAs – it adds CCA in this screw-like motion regardless of what the sequence is. So it is a mutation in the RNA itself that prevent future errors,” ensuring that proteins are made correctly.

This work was supported by grants from the US National Institutes of Health, the Howard Hughes Medical Institute, a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research, the Robertson Research Fund of Cold Spring Harbor Laboratory and the Cold Spring Harbor Laboratory Women in Science Award.

“On-Enzyme Refolding Permits Small RNA
 and tRNA Surveillance by the CCA-Adding Enzyme” appears online in Cell on January 29, 2015. The authors are: Claus-D. Kuhn, Jeremy Wilusz, Yuxuan Zheng, Peter Beal, and Leemor Joshua-Tor. The paper can be obtained online at:

About Cold Spring Harbor Laboratory

Celebrating its 125th anniversary in 2015, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory is more than 600 researchers and technicians strong. The Meetings & Courses Program hosts more than 12,000 scientists from around the world each year on its campuses in Long Island and in Suzhou, China. The Laboratory’s education arm also includes an academic publishing house, a graduate school and programs for middle and high school students and teachers. For more information, visit

Written by: Jaclyn Jansen, Science Writer | This email address is being protected from spambots. You need JavaScript enabled to view it. | 516-367-6822